Project ImPACT: Hypertension  Outcomes of a Pharmacist-Provided Hypertension Service

Nemerovski, Carrie W.; Young, Maria; Mariani, Nicholas; Bugdalski-Stutrud, Carol; Moser, Lynette R.

doi:10.24926/iip.v4i3.308

Cited by 6 publications

(13 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“… aged ≥18 years of age able to provide written informed consent to participate in study able to return for all follow-up visits (as per Figure 1 ) and were accessible by telephone had a diagnosis of essential hypertension (new diagnosis or established diagnosis) which was not controlled and meeting criteria for therapy as defined by current Australian guidelines. 12 …”

Section: Methodsmentioning

confidence: 99%

“…had a diagnosis of essential hypertension (new diagnosis or established diagnosis) which was not controlled and meeting criteria for therapy as defined by current Australian guidelines. 12 …”

Section: Methodsmentioning

confidence: 99%

“…Even dating back to the 1990s, studies have shown that community pharmacist-led services comprising patient education and blood pressure monitoring (including the use home blood pressure readings obtained from monitors that wirelessly transmit information to the pharmacy) can improve patient knowledge about hypertension, significantly decrease mean blood pressure, improve blood pressure control in those not at treatment targets, and rationalise the use of antihypertensive medication. 12 , 13 , 14 , 15 A Cochrane review also reports the positive outcomes from pharmacist-led care, with the majority of controlled trials associated with improved blood pressure control. 16 Even those studies that have focused on patient self-management (e.g., self-monitoring of BP) have shown that additional support from health professionals may enhance the BP lowering effect of any intervention.…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Implementation and evaluation of a pharmacist-led hypertension management service in primary care: outcomes and methodological challenges

Bajorek¹,

LeMay²,

Magin³

et al. 2016

Pharm Pract (Granada)

View full text Add to dashboard Cite

Background:Suboptimal utilisation of pharmacotherapy, non-adherence to prescribed treatment, and a lack of monitoring all contribute to poor blood (BP) pressure control in patients with hypertension.Objective:The objective of this study was to evaluate the implementation of a pharmacist-led hypertension management service in terms of processes, outcomes, and methodological challenges.Method:A prospective, controlled study was undertaken within the Australian primary care setting. Community pharmacists were recruited to one of three study groups: Group A (Control – usual care), Group B (Intervention), or Group C (Short Intervention). Pharmacists in Groups B and C delivered a service comprising screening and monitoring of BP, as well as addressing poor BP control through therapeutic adjustment and adherence strategies. Pharmacists in Group C delivered the shortened version of the service.Results:Significant changes to key outcome measures were observed in Group C: reduction in systolic and diastolic BPs at the 3-month visit (P<0.01 and P<0.01, respectively), improvement in medication adherence scores (P=0.01), and a slight improvement in quality of life (EQ-5D-3L Index) scores (P=0.91). There were no significant changes in Group B (the full intervention), and no differences in comparison to Group A (usual care). Pharmacists fed-back that patient recruitment was a key barrier to service implementation, highlighting the methodological implications of screening.Conclusion:A collaborative, pharmacist-led hypertension management service can help monitor BP, improve medication adherence, and optimise therapy in a step-wise approach. However, blood pressure screening can effect behaviour change in patients, presenting methodological challenges in the evaluation of services in this context.

show abstract

Section: Methodsmentioning

confidence: 99%

Section: Methodsmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Implementation and evaluation of a pharmacist-led hypertension management service in primary care: outcomes and methodological challenges

Bajorek¹,

LeMay²,

Magin³

et al. 2016

Pharm Pract (Granada)

View full text Add to dashboard Cite

show abstract

“…Interventions led by community pharmacists have demonstrated to help patients with specific chronic diseases achieve better outcomes. [8][9][10] While several continuing education programs on celiac disease do exist, the level of pharmacist knowledge regarding this disease specifically was never assessed in previous studies.…”

Section: Introductionmentioning

confidence: 99%

Exploring the Community Pharmacist’s Knowledge of Celiac Disease

Avena-Woods

Mangione

2018

American Journal of Pharmaceutical Education

View full text Add to dashboard Cite

“…The expansion of these pharmacy-based patient care activities has been overwhelmingly successful, resulting in increased vaccination rates, improved patient access to care, enhanced patient outcomes, delivery of expanded scope of patient care, and development of constructive relationships with other stakeholders involved in promoting public health. [1][2][3][4][5][6][7][8][9][10][11][12][13][14] The American Pharmacists Association (APhA) continues to build on its experience and success in pharmacy-based immunizations and other public health initiatives, and it has been exploring public health and community interest in engaging pharmacists in the administration of medications, Disclosure: Mitchel C. Rothholz and Parisa Vatanka work for the American Pharmacists Association and declare no conflicts of interest or financial interests in any product or service mentioned in this article. This includes grants (pending or received), employment, gifts, stock holdings or options, honoraria, consultancies, expert testimony, patents, and royalties for all authors and members of their immediate families.…”

mentioning

confidence: 99%

Report of the APhA Stakeholder Conference on Improving Patient Access to Injectable Medications

Skelton¹,

Rothholz²,

Vatanka³

2017

Journal of the American Pharmacists Association

View full text Add to dashboard Cite

Objectives: The APhA Stakeholder Conference on Improving Patient Access to Injectable Medications was convened to foster national dialogue to advance the pharmacist's role in the provision of injectable medication administration services (MAS) and related patient care services, and to establish pharmacy as a site of care for these injections. Participants discussed the distinct opportunities to maximize pharmacist scope of services, expand patient access to care, improve medication adherence, and enhance outcomes for patients on injectable medication therapies for a range of conditions. These elements were framed in terms of the practice model, the business model, and the necessary training and resources to support these activities. Data sources: National thought leaders within pharmacy practice, pharmacist employers, national pharmacy associations, and pharmaceutical companies were invited to participate in the conference on December 15, 2016. Participants provided perspectives on a series of structured questions around administrative and patient care issues associated with the expansion of pharmacy-based MAS. Outcomes from the discussions were supplemented with related information from the literature. Summary: The APhA Stakeholder Conference on Improving Patient Access to Injectable Medications explored how the pharmacy profession could advance a broad-based, professionwide practice model for MAS across a wide spectrum of therapeutic classes. There is a significant public health need to expand access to patients and make MAS a widely available, predictable, measurable, and scalable service provided by pharmacists. Conference participants discussed scope of practice, service delivery, and business model barriers. They also identified tools and resources that are necessary to overcome those barriers to advance opportunities and develop long-term, sustainable strategies to increase access to MAS from community-based pharmacist practitioners. Conclusion: Conference outcomes provided specific guidance around the need to develop practice support to address public health needs and effectively advance pharmacist provision of MAS and related patient care services. Key recommendations included the development of national practice guidance, standardized education and training, practice-level tools and resources, and enhanced technology solutions.

show abstract

Project ImPACT: Hypertension Outcomes of a Pharmacist-Provided Hypertension Service

Cited by 6 publications

References 23 publications

Implementation and evaluation of a pharmacist-led hypertension management service in primary care: outcomes and methodological challenges

Implementation and evaluation of a pharmacist-led hypertension management service in primary care: outcomes and methodological challenges

Exploring the Community Pharmacist’s Knowledge of Celiac Disease

Report of the APhA Stakeholder Conference on Improving Patient Access to Injectable Medications

Contact Info

Product

Resources

About